Chronic Myeloid Leukemia: Long-Term Experience of Target Therapy (original) (raw)

Treatment of Older Patients with Acute Myeloid Leukemia (AML)

Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, 2001

The Previous Treatment Value for the Nilotinib Therapy Efficiency in Patients with Chronic Myeloid Leukemia

Experimental and Clinical Physiology and Biochemistry, 2019

Symptoms following TKI therapy discontinuation after achieving an adequate response in patients with chronic myeloid leukemia in chronic phase (CML-CP)

Annie Guerin

Journal of Clinical Oncology

View PDFchevron_right

Mosaic Down Syndrome with Chronic Myeloid Leukemia: A Case Report

Rajat Biswas

Bangladesh Journal of Anatomy, 2013

View PDFchevron_right

Development of program therapy for patients with acute myeloid leukemia under the age of 60 years, based on the principles of differentiated effects

Sergei Kulikov

Terapevticheskii arkhiv

View PDFchevron_right

Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life

Elza Lomaia

Clinical oncohematology, 2017

View PDFchevron_right

Pproaches to the Assessment of Minimal Residual Disease in B-Cell Acute Lymphoblastic Leukemias in Conditions of Target Therapy

Alexander Popa

Russian Journal of Biotherapy, 2017

View PDFchevron_right

High-risk chronic lymphocytic leukemia: history, definition, diagnosis, and management

Andrey Sudarikov

View PDFchevron_right

Allogeneic haematopoietic stem cell transplantation with reduced-intensity conditioning in chronic myeloid leukaemia

L. Zubarovskaya

Russian journal of hematology and transfusiology, 2020

View PDFchevron_right

Acute Myeloblastic Leukemia and Myelodysplastic Syndrome: Azacitidine for Prophylactic and Preventive Purposes after Allogeneic Hematopoietic Stem Cell Transplantation

Vladislav Sergeev

Clinical oncohematology

View PDFchevron_right

Late myelotoxicity of high-dose chemotherapy according to the modified NHL-BFM-90 program in adult patients with diffuse large B-cell lymphoma

Sergei Kulikov

Terapevticheskii arkhiv, 2016

View PDFchevron_right

Hairy cell leukemia. Clinical recommendations

Любовь Аль-Ради

Journal of Modern Oncology, 2020

View PDFchevron_right

MLL-Negative Infant Acute Lymphoblastic Leukemia. Clinical Characteristics and Possibilities for Chemotherapy Optimization

K. Kondratchik

Russian Journal of Children Hematology and Oncology, 2017

View PDFchevron_right

[Treatment of acute lymphoblastic leukemia in children according to the ALL-BFM-90m protocol in the Russian Federation and the Republic of Belarus]

A. Rudneva

Voprosy onkologii, 2002

View PDFchevron_right

[Synchronous and metachronous myeloid and lymphoid tumors]

Anahit Melikyan, Iu Varlamova, Andrey Sudarikov, Суборцева Ирина, A. Kovrigina

Terapevticheskiĭ arkhiv, 2014

View PDFchevron_right

Immunological Synapse in the Biology of Chronic Lymphocytic Leukemia

Darima Badmazhapova

Clinical Oncohematology, 2018

View PDFchevron_right

NEW HLA-C*12:138 ALLELE, DETECTED IN A FEMALE PATIENT WITH CHRONIC MYELOID LEUKEMIA DURING SEARCH FOR UNRELATED DONOR FOR TRANSPLANTATION OF ALLOGENIC HEMOPOIETIC STEM CELLS

Andrey Sudarikov

Gematologiia i transfuziologiia

View PDFchevron_right

Relationship of Blast Cell Immunophenotype with Remission in Acute Myeloid Leukemia in Children

Александра Палладина

Российский Биотерапевтический Журнал, 2020

View PDFchevron_right

Prognostic significance of new biological markers in chronic lymphocytic leukaemia

Mirjana Gotic

Srpski arhiv za celokupno lekarstvo, 2011

View PDFchevron_right

Relation between Genomic DNA Breakpoints in MLL Gene and Treatment Outcome in Infants with Acute Leukemia

Alexander Solodovnikov

Clinical oncohematology, 2016

View PDFchevron_right

Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation

sylvain choquet

Blood, 2011

View PDFchevron_right

Translocation t(1;11)(p32;q23) with MLL-EPS15 fusion gene formation in acute leukemias: a review and 6 new case reports. Approaches to minimal residual disease monitoring

Olga Plekhanova

Onkogematologiâ, 2014

View PDFchevron_right

Haploidentical hematopoietic stem cell transplantation in the treatment of children and adolescents with resistant forms of acute leukemia

L. Zubarovskaya

Russian Journal of Children Hematology and Oncology, 2015

View PDFchevron_right

Study of Multiple Sclerosis Pathogenesis as the Basis of Its Target Therapy

Татьяна Байдина

Perm Medical Journal, 2018

View PDFchevron_right

LONG REMISSION OF PATIENT WITH CHRONIC MYELOID LEUKEMIA WITH MIXED CHYMERISM AFTER ALLOGENIC BONE MARROW TRANSPLANTATION

Andrey Sudarikov

View PDFchevron_right

Efficiency of Bone Marrow Precursor Cell Colony-Forming as a Predictor of Disease Course in Plasma Cell Myeloma Patients with a History of Radiation Exposure

T. Liubarets

Problemy radiatsiinoi medytsyny ta radiobiolohii, 2020

View PDFchevron_right

The influence of various doses of busulfan in conditioning regimes on outcome of allogeneic hematopoietic stem cell transplantation in children with acute myeloid leukemia

L. Zubarovskaya

Pediatric Hematology/Oncology and Immunopathology, 2020

View PDFchevron_right

Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)

Lars Munksgaard

Blood, 2016

View PDFchevron_right

Short- and long-term outcomes from the upfront high-dose chemotherapy, followed by autologous hematopoietic stem cell transplantation in diffuse large B-cell lymphoma

Anna Artemyeva

Meditsinskiy sovet = Medical Council

View PDFchevron_right

Frequency of coexistence and kinetics of the BCR-ABL1 transcript level and allele burden of JAK2V617F and CALR Type 1, 2 gene mutations in patients with chronic myeloid leukemia

T. Makarik

Russian journal of hematology and transfusiology, 2020

View PDFchevron_right

High-dose polychemotherapy with autologous hematopoietic stem cell transplantation in children with non-Hodgkin lymphomas

vadim baykov

Pediatric Hematology/Oncology and Immunopathology, 2021

View PDFchevron_right

Prognostic markers of efficiency of immunosupressive therapy in patients with myelodysplastic syndrome

Мар'яна Сімонова

ScienceRise, 2015

View PDFchevron_right

Induction therapy and the role of stem cell transplantation in the treatment of myeloma multiplex in patients aged below 65 years

Bela Balint

Srpski arhiv za celokupno lekarstvo, 2011

View PDFchevron_right

Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases

Elza Lomaia

Terapevticheskii arkhiv, 2018

View PDFchevron_right

Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trial

R. Powles

The Lancet, 1990

View PDFchevron_right

Chronic Myeloid Leukemia: Long-Term Experience of Target Therapy (original) (raw)

Related papers